BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 35727403)

  • 1. Targeting autophagy as a therapeutic strategy against pancreatic cancer.
    Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K; Fujishiro M
    J Gastroenterol; 2022 Sep; 57(9):603-618. PubMed ID: 35727403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.
    Reyes-Castellanos G; Abdel Hadi N; Carrier A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer.
    Yamamoto K; Venida A; Perera RM; Kimmelman AC
    Autophagy; 2020 Aug; 16(8):1524-1525. PubMed ID: 32459143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.
    Zhang Z; Song B; Wei H; Liu Y; Zhang W; Yang Y; Sun B
    Drug Resist Updat; 2024 Mar; 73():101040. PubMed ID: 38228036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy is critical for cysteine metabolism in pancreatic cancer through regulation of SLC7A11.
    Mukhopadhyay S; Kimmelman AC
    Autophagy; 2021 Jun; 17(6):1561-1562. PubMed ID: 33985415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
    Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC
    Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Metabolic Rewiring in Pancreatic Cancer and Its Tumor Microenvironment.
    Yamamoto K; Iwadate D; Kato H; Nakai Y; Tateishi K; Fujishiro M
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and function of autophagy in pancreatic cancer.
    Li J; Chen X; Kang R; Zeh H; Klionsky DJ; Tang D
    Autophagy; 2021 Nov; 17(11):3275-3296. PubMed ID: 33161807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy supports mitochondrial metabolism through the regulation of iron homeostasis in pancreatic cancer.
    Mukhopadhyay S; EncarnaciĆ³n-Rosado J; Lin EY; Sohn ASW; Zhang H; Mancias JD; Kimmelman AC
    Sci Adv; 2023 Apr; 9(16):eadf9284. PubMed ID: 37075122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose-Induced mTORC1 Activation Promotes Pancreatic Cancer Progression through Inhibition of Autophagy.
    Cui Y; Tian J; Wang Z; Guo H; Zhang H; Wang Z; Liu H; Song W; Liu L; Tian R; Zuo X; Ren S; Niu R; Zhang F
    Cancer Res; 2023 Dec; 83(24):4063-4079. PubMed ID: 37738413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor heterogeneity: An oncogenic driver of PDAC progression and therapy resistance under stress conditions.
    Palma AM; Vudatha V; Peixoto ML; Madan E
    Adv Cancer Res; 2023; 159():203-249. PubMed ID: 37268397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.
    Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms.
    Yang A; Herter-Sprie G; Zhang H; Lin EY; Biancur D; Wang X; Deng J; Hai J; Yang S; Wong KK; Kimmelman AC
    Cancer Discov; 2018 Mar; 8(3):276-287. PubMed ID: 29317452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis.
    Fan M; Huo S; Guo Y; Wang R; Hao W; Zhang Z; Wang L; Zhao Y
    Cell Rep; 2024 Feb; 43(2):113808. PubMed ID: 38367236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer.
    Sang W; Zhou Y; Chen H; Yu C; Dai L; Liu Z; Chen L; Fang Y; Ma P; Wu X; Kong H; Liao W; Jiang H; Qian J; Wang D; Liu YH
    Cancer Discov; 2024 Feb; 14(2):326-347. PubMed ID: 37824278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy is required for proper cysteine homeostasis in pancreatic cancer through regulation of SLC7A11.
    Mukhopadhyay S; Biancur DE; Parker SJ; Yamamoto K; Banh RS; Paulo JA; Mancias JD; Kimmelman AC
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33531365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
    Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
    Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status.
    Yang A; Kimmelman AC
    Autophagy; 2014 Sep; 10(9):1683-4. PubMed ID: 25046107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.